Nasal immune cell spray passes first safety check in small study
Knowledge-focused
Completed
This early-stage study tested whether a nasal spray containing immune cells from a male donor is safe for healthy women aged 18 to 55. Nine participants received the spray and were monitored for side effects over a week. The goal was only to check safety and tolerability, not to …
Phase: PHASE1 • Sponsor: Cristina Calvo Rey • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:06 UTC